Current Neuro-Oncology




Volume 27 Number 12
30 April 2025




Home > Publications > Current Neuro-Oncology > Volume 27, Year 2025 > Number 12, 30 April






Larroquette M, Bronnimann C, Ollivier M, Daubon T, Lesueur P, Ramirez C, Idbaih A, Kalamarides M, Peyre M, Engelhardt J.
Carboplatin-gemcitabine for refractory high-grade meningiomas: A study from the French national OMEGA consortium.
Int J Cancer. 2025 Apr 21. doi: 10.1002/ijc.35453. PMID: 40257320. Observational study˰ ˍ




*Lally AR, Ghosh SR, Pecorari IL, Reynolds J, Ledet A, Begley S, Diaz EJ, Zhu E, Joseph K, McGeehan K, Schulder M, Johanns T, Ziemba YC, Agarwal V.
Do the benefits of IDH mutations in high-grade glioma persist beyond the first recurrence? A multi-institutional retrospective analysis.
J Neurooncol. 2025 Apr 22. doi: 10.1007/s11060-025-05049-2. PMID: 40261557. Observational study. ˍ




Roy JM, Prvulovic ST, Warrier A, Mousavi AK, Bhalla S, Sanchez D, Jagtiani P, Verma V, Varghese JR, Sanmuganthan P, Delashaw J, Bowers CA.
Failure to Rescue After Brain Tumor Resection: A National Surgical Quality Improvement Program Analysis (2012-2020).
Neurosurgery. 2025 Apr 23. doi: 10.1227/neu.0000000000003472. PMID: 40265928. Observational study˰ ˍ




Yi GZ, Lin JF, Lu YX, Li ZY, Qu SQ, Feng WY, Huang GL.
Clinical, pathological, radiological features and prognosis of epithelioid glioblastoma: a retrospective single center study.
J Neurooncol. 2025 Apr 23. doi: 10.1007/s11060-025-05046-5. PMID: 40266499. Observational study˰ ˍ




Al Kharbooshi JYA, Al Otaibi SSFJ, Pejhan S, Climans SA, Chan TLH.
Alice in Wonderland syndrome caused by a right parietooccipital astrocytoma.
Can J Neurol Sci. 2025 Apr 24:1-8. doi: 10.1017/cjn.2025.83. PMID: 40269586. Case report˰ ˍ




Behrooz AB, Latifi-Navid H, Zolfaghari N, Piroozmand S, Pour-Rashidi A, Bourbour M, Jusheghani F, Aghaei M, Azarpira N, Mollasalehi F, Alamdar S, Nasimian A, Lotfi J, Shojaei S, Nazar E, Ghavami S.
Metabolic reprogramming in glioblastoma: a rare case of recurrence to scalp metastasis.
BJC Rep. 2025 Apr 24;3(1):27. doi: 10.1038/s44276-025-00134-5. PMID: 40274950. Case report. ˍ




Du R, Maierdan M, Yusufu A, Dong S, Cai X, Xu T, Sheng W, Maimaiti M.
Causal Association Between Sleep Deprivation and Glioblastoma Risk: Insights from Multi-Omics Analysis.
J Mol Neurosci. 2025 Apr 24;75(2):56. doi: 10.1007/s12031-025-02354-3. PMID: 40272711. Laboratory investigation. ˍ




Faison SL, Batonga J, Arumugham T, Bartkus A, Morrison ME, Mullin MJ, Tippin T, Naderer O.
A phase 1, randomized, crossover trial to assess the effect of itraconazole on the pharmacokinetics of dordaviprone in healthy adults.
Br J Clin Pharmacol. 2025 Apr 27. doi: 10.1002/bcp.70080. PMID: 40289283. Interventional study˰ ˍ




Weathers SP, Li X, Zhu H, Damania AV, Knafl M, McKinley B, Lin H, Harrison RA, Majd NK, O'Brien BJ, Penas-Prado M, Loghin M, Kamiya-Matsuoka C, Yung WKA, Solis Soto LM, Maru DM, Wistuba I, Parra Cuentas ER, Hernandez S, Futreal A, Wargo JA, Schulze K, Darbonne WC, Ajami NJ, Woodman SE, de Groot JF.
Improved overall survival in an anti-PD-L1 treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single arm prospective phase I/II trial.
Nat Commun. 2025 Apr 27;16(1):3950. doi: 10.1038/s41467-025-56930-7. PMID: 40289138. Interventional study. ˍ




Bien-Möller S, Weidemeier ME, Radke J, Baldauf J, Engeli S, Tzvetkov MV, Schroeder HWS.
Case report of three patients with end-stage recurrent glioblastoma treated with meldonium.
BJC Rep. 2025 Apr 28;3(1):29. doi: 10.1038/s44276-025-00124-7. PMID: 40295665. Case report. ˍ




Ghaedian T, Alipour A, Rakhsha A, Nasrollahi H, Ghaedian M, Andalibi S, Saffarian A.
Excellent Response of Glioblastoma Multiforme to [ 177 Lu] Lu-PSMA Therapy.
Clin Nucl Med. 2025 Apr 28. doi: 10.1097/RLU.0000000000005904. PMID: 40279656. Case report˰ ˍ




Leppert J, Ditz C, Matschke J, Krenzlin H, Keric N, Ziemann C, Hahn L, Matone MV, Liubich L, Streubel K, Schacht H, Hillbricht C, Kuppler P, Rades D, Löser A.
Sex-related Survival Differences in Patients With Glioblastoma - Results From a Retrospective Analysis.
Anticancer Res. 2025 Apr 28;45(5):2059-2069. doi: 10.21873/anticanres.17580. PMID: 40295065. Observational study. ˍ




La Rosa A, Mittauer KE, Rzepczynski AE, Chuong MD, Bassiri-Gharb N, McAllister NC, Hall MD, Press RH, Gutierrez AN, Tolakanahalli R, Mehta MP, Kotecha R.
Temporospatial tumor dynamic changes in glioblastoma during radiotherapy.
J Neurooncol. 2025 Apr 29. doi: 10.1007/s11060-025-05060-7. PMID: 40299247. Observational study˰ ˍ